Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew C Good

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Journal of Medicinal Chemistry|March 28, 2018
Bicyclic Helical Peptides as Dual Inhibitors Selective for Bcl2A1 and Mcl-1 ProteinsAline D de Araujo, Junxian Lim, Kai-Chen Wu, et al.
Bioorganic & Medicinal Chemistry Letters|April 21, 2009
Synthesis and SAR of hydroxyethylamine based phenylcarboxyamides as inhibitors of BACEYong-Jin Wu, Yunhui Zhang, Andrew C Good, et al.
Journal of Molecular Graphics & Modelling|June 12, 2003
Analysis and optimization of structure-based virtual screening protocols. 2. Examination of docked ligand orientation sampling methodology: mapping a pharmacophore for successAndrew C Good, Daniel L Cheney, Doree F Sitkoff, et al.
Organic Letters|December 6, 2002
Pyrrolidine-5,5-trans-lactams. 2. The use of X-ray crystal structure data in the optimization of P3 and P4 substituentsDavid M Andrews, Helene Chaignot, Barry A Coomber, et al.
Journal of Medicinal Chemistry|February 18, 2010
Molecular shape and medicinal chemistry: a perspectiveAnthony Nicholls, Georgia B McGaughey, Robert P Sheridan, et al.
Journal of Medicinal Chemistry|February 21, 2012
Implications of promiscuous Pim-1 kinase fragment inhibitor hydrophobic interactions for fragment-based drug designAndrew C Good, Jinyu Liu, Bradford Hirth, et al.
Bioorganic & Medicinal Chemistry Letters|December 25, 2016
Structure-activity relationships of 4-hydroxy-4-biaryl-proline acylsulfonamide tripeptides: A series of potent NS3 protease inhibitors for the treatment of hepatitis C virusAlan Xiangdong Wang, Jie Chen, Qian Zhao, et al.
Bioorganic & Medicinal Chemistry Letters|June 28, 2013
HCV NS5A replication complex inhibitors. Part 5: discovery of potent and pan-genotypic glycinamide cap derivativesMakonen Belema, Van N Nguyen, Denis R St Laurent, et al.
Bioorganic & Medicinal Chemistry Letters|July 20, 2015
Discovery, design, and synthesis of indole-based EZH2 inhibitorsVictor S Gehling, Rishi G Vaswani, Christopher G Nasveschuk, et al.
Bioorganic & Medicinal Chemistry Letters|April 14, 2018
P3-P4 ureas and reverse carbamates as potent HCV NS3 protease inhibitors: Effective transposition of the P4 hydrogen bond donorBrian L Venables, Ny Sin, Alan Xiangdong Wang, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Journal of Medicinal Chemistry|March 28, 2018
Bicyclic Helical Peptides as Dual Inhibitors Selective for Bcl2A1 and Mcl-1 ProteinsAline D de Araujo, Junxian Lim, Kai-Chen Wu, et al.
Bioorganic & Medicinal Chemistry Letters|April 21, 2009
Synthesis and SAR of hydroxyethylamine based phenylcarboxyamides as inhibitors of BACEYong-Jin Wu, Yunhui Zhang, Andrew C Good, et al.
Journal of Molecular Graphics & Modelling|June 12, 2003
Analysis and optimization of structure-based virtual screening protocols. 2. Examination of docked ligand orientation sampling methodology: mapping a pharmacophore for successAndrew C Good, Daniel L Cheney, Doree F Sitkoff, et al.
Organic Letters|December 6, 2002
Pyrrolidine-5,5-trans-lactams. 2. The use of X-ray crystal structure data in the optimization of P3 and P4 substituentsDavid M Andrews, Helene Chaignot, Barry A Coomber, et al.
Journal of Medicinal Chemistry|February 18, 2010
Molecular shape and medicinal chemistry: a perspectiveAnthony Nicholls, Georgia B McGaughey, Robert P Sheridan, et al.
Journal of Medicinal Chemistry|February 21, 2012
Implications of promiscuous Pim-1 kinase fragment inhibitor hydrophobic interactions for fragment-based drug designAndrew C Good, Jinyu Liu, Bradford Hirth, et al.
Bioorganic & Medicinal Chemistry Letters|December 25, 2016
Structure-activity relationships of 4-hydroxy-4-biaryl-proline acylsulfonamide tripeptides: A series of potent NS3 protease inhibitors for the treatment of hepatitis C virusAlan Xiangdong Wang, Jie Chen, Qian Zhao, et al.
Bioorganic & Medicinal Chemistry Letters|June 28, 2013
HCV NS5A replication complex inhibitors. Part 5: discovery of potent and pan-genotypic glycinamide cap derivativesMakonen Belema, Van N Nguyen, Denis R St Laurent, et al.
Bioorganic & Medicinal Chemistry Letters|July 20, 2015
Discovery, design, and synthesis of indole-based EZH2 inhibitorsVictor S Gehling, Rishi G Vaswani, Christopher G Nasveschuk, et al.
Bioorganic & Medicinal Chemistry Letters|April 14, 2018
P3-P4 ureas and reverse carbamates as potent HCV NS3 protease inhibitors: Effective transposition of the P4 hydrogen bond donorBrian L Venables, Ny Sin, Alan Xiangdong Wang, et al.
Pageof 4